Try our Advanced Search for more refined results
Health - April, 2011
270 articles
- Actelion Must Pay Asahi $550M In Fasudil Suit: Jury
- Ex-MedQuist CFO Settles SEC Suit Over Billing Fraud
- Ex-Hospital Exec Gets Bench Trial In Bribery Case
- Billups' Gene Test Patents Are Invalid: Fed. Circ.
- Big Tobacco Wins $455M Fight Against Mo. Hospitals
- New Medicare Program Rewards Hospitals For Performance
- How The FDA Can Compel Post-Marketing Studies
- Lilly, SEC Push Toward Deal In FCPA Probe
- DC Circ. OKs Funding For Embryonic Stem Cell Research
- Mass. Hospital Wins Gene Patent Inventorship Fight
- Expertly Navigating Federal Expert Disclosure Rules
- Celgene Sues Americord Over Stem Cell Marketing
- Shire Sues Sandoz Over Planned Generic Intuniv
- Allergan Hit With $212M Verdict In Botox Suit
- Researcher Renews CVS Fight Over Prescription Data
- EU Probes Cephalon, Teva Deal Over Generic Provigil
- CHS Rebuts Tenet Medicare Fraud Claims
- FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan
- Merck To Abide By Discharge Diet To End Enviro Suit
- NAIC Wins Suit Over Medicare Supplement Criticisms
- Davis Polk Reps Aetna In $600M Prodigy Health Buy
- Using Injunctions In 'Bet-The-Company' Litigation
- Weighing Generic Litigation In The ITC
- Par Pharmaceutical Settles Medicaid Suits For $154M
- Lilly Wins Order Banning Generic Cymbalta Sales
- Abbott Appeals $3.5M OT Ruling In 7th Circ.
- Genzyme Sues Over Endo's Bid To Sell Generic Renvela
- Asahi, Actelion Throw Final Punches In Fasudil IP Row
- Mayo Wins Trade Secrets Verdict Against Ex-Employee
- Prexus Wins $8M Verdict In Texas Contract Suit
- Duane Reade Settles Medicaid Fraud Suit
- Albemarle Hit With CWA Suit Over Pharma Production
- FOIA Request Filed As Avastin Safety Hearing Nears
- Hospira, Others Sued Over Infusion Pump Patent
- FTC Orders Hikma To Shed Drugs For $112M Baxter Deal
- Cravath, Weil Rep J&J In $21B Deal To Buy Synthes
- Mo. Lt. Gov. Loses Health Care Reform Suit
- Hospital Group To Appeal PPACA Suit Dismissal
- High Court Mulls Vt. Limits On Use Of Drug Data
- Former NC Chief Justice, 3 Others Join Nexsen Pruet
- UnitedHealth, Workers Should Arbitrate OT Row: Judge
- Elan Targets Teva Again Over Generic Focalin XR
- $251M Animal Health Co. Merger Moves Forward
- Metro Med Workers Sentenced For $23M Medicare Fraud
- Genzyme Asks To Add New Patent To Arthritis Drug Suit
- Pharmacist Hits Omnicare With Meal Break Class Action
- Judge Allows Revival Of Claims In Radiology FCA Suit
- FDA To Repackage E-Cigarettes As Tobacco Products
- Baxter, CSL Look To Nix County's Blood Plasma Suit
- WHPM Hit With $20M Suit Over Drug Test Kits
- No Proof For Bayer's Probiotics Claims, Suit Says
- Supreme Court Rejects Fast-Track Health Care Appeal
- Mutual Sues West-Ward Over Gout Drug Patents
- Community Health Under Microscope For Medicare Billing
- AstraZeneca, Pozen Sue Dr. Reddy's Over Vimovo Patent
- St. Jude Wins $2.3B Verdict In Trade Secrets Trial
- Employers With No-Smokers Policies Could Get Burned
- Northgate Infringes Lexion Laparoscopy IP: Fed. Circ.
- Fast-Track Patent Review Delayed By Budget Woes
- Yaz, Similar Pills Tied To Higher Blood Clot Risks
- Tenet Healthcare Again Rejects $3.3B CHS Bid
- FTC Won't Bar LabCorp's $58M Westcliff Tie-Up
- Plaintiffs Fear Retaliation In MiraLax Antitrust Suit
- Genentech Sues Sandoz Over Generic Valcyte
- The Dawn Of Internet Privacy?
- Judge Nixes New Trial For Braun, Terumo Catheter Row
- Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara
- ERISA Preempts Hospital's Contract Claims: 2nd Circ.
- Fund Wants J&J To Pay Up For Faulty Hip Implants
- Class Cert. Denied In Pitt ADA Suit
- Cardinal Health Settles Kickback Claims For $8M
- Calif. Calls On Blue Shield To Explain 38% Rate Hike
- FDA Cautions Lifetech Over Eyelash Growth Products
- Feds Seek Deal Time In $3M FDA Chemist Trading Case
- Sanofi Free To Appeal Genentech Patent Ruling
- GSK, Scottrade Settle IP Suits Over Navy Technology
- Medicaid Claims Processor Dodges FCA Suit
- Shire Sues Mylan Over Intuniv Patents
- Wyeth, Dr. Reddy's Strike Deal Over Effexor Patents
- Certifying To Medical Necessity Under FDA
- Contractor Wants Hospital Kickback Case Pruned
- Feds Want GSK VP To Testify In Wellbutrin Case
- Aetna Loses Bid To Re-Enter Pfizer Off-Label MDL
- Bayer Sues Mylan Over Generic Yaz
- Novartis Targets Teva Over Myfortic Patents
- FTC Seeks To Block Ga. Hospital Merger
- The Scope Of Protective Orders For Medical Records
- No New Trial For Former InterMune CEO
- US Cracks Down On Prescription Drug Abuse
- Judge Tosses Most Claims In Medtronic Class Action
- Marketing Reps Hit Amerigroup With OT Class Action
- Off-Label Use Of Novo Drug May Harm Patients: Study
- AstraZeneca Sued Over Nexium Bone Fracture Risks
- Texas Hospital Fights To Sink Medicare Fraud Suit
- 2nd Circ. Nixes Suit Over University's Medicare Bills
- FTC Clears Warburg's $438M Rural/Metro Buyout
- Genzyme, Daiichi Sue Watson Over Generic Welchol
- Mich. Hospitals Try To Nix Price-Fixing Action
- Baker & Daniels Adds 2 Partners In Chicago
- Defense Absent As St. Jude Trade Secrets Trial Begins
- Caraco Investors Seek Class Cert. In Stock Price Suit
- Suits Force Celera's Hand On $344M Merger With Quest
- Skilling Ruling Dooms Hospital Bribery Case: Contractor
- Allergan Targets Sandoz Over Generic Latisse
- McCarter Adds Patent Attorney From Foley & Lardner
- Synthes Confirms Potential $20B Acquisition By J&J
- AstraZeneca, P&G Dodge Prilosec OTC Antitrust Suit
- CHS Moves To All-Cash Bid In Tenet Merger Battle
- 'Love And Other Drugs' In Real Life
- Harmonizing FDA Foreign And Domestic Inspections
- Welcome To The New Law360
- Merck, J&J Strike Deal In Arthritis Drugs Dispute
- FDA Ducks ViroPharma Suit Over Generics Guidelines
- Biotech Co., Mintz Levin Settle Suit Over Patents
- CVS Pays $17.5M To End False Claims Act Suit
- UK To Ban Lethal Injection Drug Exports To US
- Cypress Sued Over Unapproved Cold Medication
- FDA Issues Safety Warning On Teva's Generic Prevacid
- FTC Must Break Up CVS Caremark: Consumer Groups
- Ala. High Court Again Rejects Scrushy Appeal
- Gentiva Clinicians Win Conditional Cert. In Pay Suit
- Calif. Court Lets P&G Fight Align Suit On Home Turf
- Judge Blocks Par Pharma's Generic Treximet
- Wyeth, Orchid Reach Deal In Effexor Patent Fight
- Making Good Lawyers Into Great Partners
- UK Court Strikes Down Infosint Patent In Citalopram Suit
- Health Care Co. Owners Cop To $200M Medicare Fraud
- UHS Demands More Info From Rival In Antitrust Suit
- NH Can Deduct Premium From Pensions, Court Rules
- House Committee Advances Amended Patent Bill
- UBS Urges 2nd Circ. To Nix Hospital Co.'s ARS Win
- Ex-InterMune CEO Gets House Arrest For Drug Claims
- Ex-GSK Lawyer Faces New Obstruction Indictment
- Genzyme Sues Seikagaku Over Synvisc-One Patent
- FDA Recalls Radiation Shield That Sheds Tungsten
- Axcan To Pay Up To $230M For Rival Mpex
- Penumbra Pulls Aneurysm Device Over Deadly Defects
- JPML To Weigh Consolidation Of Darvocet Cases
- Arguments On Appeal: FTC V. Lundbeck
- Takeda Drops Suit Over Apotex's Actos ANDA
- J&J Recalls 57K Bottles Of Topamax Over Odor
- House Votes To Strip $18B Health Care Law Fund
- Coventry Seeks KO In Securities Class Action
- HGS Fires Round 2 At Genentech Over Lupus Drug IP
- Bill Seeks To Temper FDA Oversight Of Drug Imports
- FDA Warns Philips Over Fatal Defibrillator Defects
- Zyprexa Payors Ask High Court For Shot At Eli Lilly
- FDA Must Improve Medical Device Oversight, GAO Says
- Vioxx MDL Attys Want 3 Firms Backing Fee Plan KO'd
- FDA Urged To Help Get Prandin Row To High Court
- Smiths Medical Sued Over Suction System Patent
- Calif. Wades Into Sutter Health Insurance Fraud Suit
- Lawyers Trade Blows Over Asahi, Actelion Trial Conduct
- MetroPlus, HHC Evade State Claims In OT Action
- Baker Donelson Lures Ala. Health Care Vet
- Braun Can't Dodge False Marking Claims On IV Fluids
- Judge Says Cordis Stent Infringes BSC Patent
- Medical Supplier Gets 6 Months For Hussein Kickbacks
- Quest's $344M Celera Buy Averts Antitrust Hurdle
- Feds Charge FrontPoint Trader In $30M Inside Tips Case
- Allied Health Founder Cops To $87M Lease Fraud
- Moog Infusion Pumps Face Class I Recall
- Medical Group Kept Egg Prices Low, Donor Claims
- Judge Trims State Claims From Res-Care FLSA Suit
- Hospitals Urge Court To Revive UnitedHealth Fraud Suit
- Fed. Circ. Rejects McKesson's Bid To Revive IP Suit
- Inspire Investor Challenges $430M Merck Deal
- Parties Offer Bellwether Plan In NuvaRing MDL
- Democrat AGs Defend Health Care Law In 11th Circ.
- NY Legislators, 6 Others Deny Bribery Charges
- Ropes & Gray Nabs IP Litigator From Sidley
- Practice Advice For Privacy Breaches
- Fresenius Dialysis Device Faces FDA Scrutiny
- Chem Rx Liquidation Plan Wins OK After Amendments
- Hologic Sues IZI Over Mammogram Cushion Patent
- Sidley Reps SXC In UMass Benefits Manager Pickup
- Dr. Comfort, Founder To Pay $27M For Medicare Fraud
- Purdue Sues Impax, Ranbaxy Over Generic OxyContin
- Revlimid Cancer Woes Spark FDA Safety Review
- Mo. AG Backs Health Care Law Challenge In 11th Circ.
- Tenet Lobs Fraud Suit At Hostile Suitor CHS
- FTC Blesses Kindred's $1.3B RehabCare Purchase
- The Latest On Advance Directives
- Former US Rep. Stupak Joins Venable Policy Group
- Merck, Sun Pharma Form Generics Joint Venture
- Skadden Reps Endo In $2.9B American Medical Buy
- Quest Settles Suit Over Unpaid Cell Phone Expenses
- Subcontractors Denied Cert. In $13M UnitedHealth Suit
- Judge Says No To Generic Amrix
- Nautilus Sues Wockhardt Over Cambia ANDA
- Abbott To Pay $52M To Norvir Direct Purchaser Class
- Pfizer Wins Approval Of Unit's $265M Asbestos Deal
- DOJ Backs $245M Stericycle Deal With Plant Sale
- UK Court Shutters Merck's Cosopt Patent Fight
- St. Vincent's Inks $260M Sale To Real Estate Kingpin
- GSK Rival Barred From Infringing Aquafresh Mark
- No Sympathy For Off-Label Scripts Suits
- Fla. Marketing Director Cops To $100M Medicare Fraud
- Investor Sounds Siren On $438M Offer For Rural/Metro
- J&J Pays $78M To Settle Foreign Bribery Cases
- NY Lawmakers, Hospital CEOs Get More Bribery Charges
- Judge Nixes Releases In Chem Rx Ch. 11 Plan
- FDA Blasts Mylan Suit Over Generic Lipitor Exclusivity
- AmSurg Nabs Rival Surgery Center Operator For $174M
- Minsurg Infringement Claims Survive Dismissal Bid
- Alcon Sues Watson Over Vigamox Patents
- Shareholder Suits Over Genoptix Sale Consolidated
- Blinded Mexican Patients Can Bring US Suit: 9th Circ.
- Angiotech Wins US Approval Of Canada Restructuring
- UnitedHealth Wins Protest Of Military Care Contract
- Kaye Scholer Reps Novartis In $420M Elidel Sale
- Canopy Ex-CEO Must Pay Back $2M For $93M Fraud
- Deformed Consent
- Judge Tosses Challenge To FDA Supplement Rules
- FDA Orders Seizure Of $6M In Products At Triad Plant
- House Panel Advances Bills To Defund Health Care Law
- Ex-Unilab GC Participation Dooms Relator's FCA Case
- Fla. Hospital Not Immune To FCA Suit, US Says
- Jury To Weigh Lost Profits In Neurontin Patent Fight
- Shire Sues Watson Again Over Adderall Patents
- Ex-NY Sen. Espada, Son Deny Corruption Charges
- Is It Material? Depends On Who You Ask
- Cravath Reps Genpact In $550M Headstrong Buy
- The FTC And State Health Care Regulation
- Cephalon Board Rejects Valeant's $5.7B Merger Bid
- Health Net Could Pay $180M Over Failed HMOs
- EMS Investors Add Goldman Sachs To Suit Over Buyout
- Pfizer Securities Fraud Suit Must Stay In NJ: Judge
- Ortho Can't Shake False Marking Claims On 5 Drugs
- Galderma, Dermalogix End Clobex Suit Against Paddock
- Eckert Seamans Snags Ex-Mass. Rep. Delahunt
- 166 Plaintiffs Tossed From Neurontin MDL
- Claims Trimmed In Radiology Co. Qui Tam Suit
- Fed. Circ. Mulls Smith & Nephew $5.2M Patent Win
- FTC Clears Cephalon's $225M Gemin X Buyout
- Palmetto Targets AstraZeneca's Crestor In IP Suit
- Hill-Rom Targets Stryker Over Bed, Stretcher Patents
- Ex-AmeriPath Manager Breached Noncompete: Judge
- Waiting For An Adult Conversation On Health Care
- Fried Frank Reps Merck In $430M Inspire Deal
- 7 Ways To Avoid Privacy And Data Security Trouble
- Lilly Sues Generics Maker Over Zyprexa Patent
- Lupin Unit Sues Ranbaxy Again Over Generic Antara
- HHS Wants To Loosen Medicare Supplier Rules
- Conceptus Fired Salesman For Overbilling Report: Suit
- Congress Can Mandate Health Insurance, US Says
- Amgen Expert Report Allowed In Aranesp Kickback Suit
- Myriad Pushes For Isolated DNA Patents In Fed. Circ.
- Cubist, Teva Settle IP Suit Over Generic Cubicin
- NC Hospital To Pay $1.9M To End Medicare Fraud Suit
- Abbott, Elan Drop Tricor IP Suits Against Biovail
- WellPoint, Ex-Workers Settle Age Bias Suits For $2.6M
- Takeda Targets Dr. Reddy's Over Generic Dexilant
- A Winning Strategy For Beating IPO Class Actions
- Taming Of The 'Ostrich Officers'
- Ohio Willow Dodges Sanctions In Prosthetics IP War
- Simpson Reps KKR In $2.4B Pfizer Capsule Unit Buy
- ReGen Using Menaflex IP After Rights Transfer: Suit
- BSC Poached Worker Suit To Move Forward In Calif.
- Eurand, Anesta Sue Anchen Over Generic Amrix
- DOJ Sues Healthpoint Over Zenaderm Marketing
- Stryker Claims Zimmer Stole Employees
- Mintz Levin Lures Ober Kaler Health Antitrust Guru
- Dead Ala. Woman's Estate Sues Over Tainted IV
- US, EU Antitrust Heads Vow Cooperation, Enforcement
- Allergan Sues Lupin Over Zymaxid Patents
- Drug Test Co. Lured Doctors With Kickbacks, Rival Says
- HIF, BizBiotech Must Face IP Claims In Federal Court
- Navigating The Medicare Secondary Payer Minefield
- Judge Denies Injunction In Animal Imaging IP Spat